Investing Profile

Vasudev Bailey

VC
General Partner at ARTIS Ventures
av.co/vasudev-baileySan Francisco, California
Photo of Vasudev Bailey, General Partner at Artis Ventures (AV)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Artis Ventures (AV) General Partner
$250K - $25.0M
$10.0M
18
CompanyStageDateRound SizeTotal Raised
Eko Health
Series DJun 2024$41M
Series CNov 2020$65M
Series BSep 2019$20M
Series AMar 2018$5M
$140M
Co-investors: Stephen Hays (What If Ventures), Pieter Kemps (Peak XV Partners (formerly Sequoia Capital India & SEA)), Rob Toews (Radical Ventures), Corey Mulloy (Highland Capital Partners), Ryan Drant (Questa Capital)
OverT Bio
SeedMay 2024$16M
$16M
Co-investors: Sara Choi (Wing Venture Capital)
Freenome
Series UnknownFeb 2024$250M
Series DDec 2021$300M
Series BJul 2019$160M
$1.1B
Co-investors: Skip Fleshman (Asset Management Ventures), Jeffrey Schwartz (Bain Capital Life Sciences), Daniel Coley (Cofounders Capital), Anne Wojcicki
Unnatural Products
Series ADec 2023$32M
SeedSep 2019$6M
$38M
Co-investors: Ameena El-Bibany (Artis Ventures (AV))
Ozlo Sleep
Series AAug 2023$10M
$10M
ONI
Series BDec 2021$75M
$75M
Co-investors: Keith Crandell (ARCH Venture Partners), Paul Conley (Paladin Capital Group), Mike Pellini (Section 32)
Delix Therapeutics
Series ASep 2021$70M
$70M
Co-investors: Ken Belotsky (Negev Capital), Matias Serebrinsky (PsyMed Ventures)
Excision BioTherapeutics
Series AFeb 2021$60M
SeedSep 2017$10M
$81M
Co-investors: Chris Sklarin (Alumni Ventures ), Anton Simunovic (Alumni Ventures ), Brian Keil (Alumni Ventures ), Ben Kong (Rebel Fund), Lawrence Jen (Anderson Angels), Daniel Rothman